CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3β

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6282-6295

  Escribano, Cristina ^a   Delgado Martín, Cristina ^a   Luis Rodriguez Fernandez, José ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL SURVIVAL; CHEMOTAXIS; DENDRITIC CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; APOPTOSIS; CELL SURVIVAL; CHEMOKINE CCL19; CHEMOKINE CCL21; DENDRITIC CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FORKHEAD TRANSCRIPTION FACTORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; I-KAPPA B KINASE; LITHIUM CHLORIDE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CCR7; SIGNAL TRANSDUCTION; THIAZOLES; UREA;

EID: 75949094175     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804093     Document Type: Article

References (73)

1. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J. W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142.
2. Steinman, R. M. 2007. Dendritic cells: versatile controllers of the immune system. Nat. Med. 13: 1155-1159.
3. Ruedl, C., P. Koebel, and K. Karjalainen. 2001. In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J. Immunol. 166: 7178-7182. (Pubitemid 32525590)
4. Kamath, A. T., S. Henri, F. Battye, D. F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100: 1734-1741.
5. Garg, G., A. Oran, J. Wajchman, S. Sasaki, C. M. Maris, J. A. Kapp, and J. Jacob. 2003. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin derived dendritic cells in vivo. Nat. Immunol. 4: 907-912.
6. Moon, J. J., H. H. Chu, M. Pepper, S. J. McSorley, S. C. Jameson, R. M. Ked, and M. K. Jenkins. 2007. Naive CD4 T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
7. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
8. Nopora, A., and T. Brocker. 2002. Bcl-2 controls dendritic cell longevity in vivo. J. Immunol. 169: 3006-3014. (Pubitemid 35013143)
9. Hou, W. S., and L. Van Parijs. 2004. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 5: 583-589.
10. Hildeman, D., T. Jorgensen, J. Kappler, and P. Marrack. 2007. Apoptosis and the homeostatic control of immune responses. Curr. Opin. Immunol. 19: 516-521.
11. Chen, M., L. Huang, and J. Wang. 2007. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109: 4360-4367.
12. Randolph, G. J., J. Ochando, and S. Partida-Sánchez. 2008. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26: 293-316.
13. Cyster, J. G. 2000. Leukocyte migration: scent of the T zone. Curr. Biol. 10: R30-R33.
14. Randolph, G. J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13: 267-274.
15. Yanagawa, Y., and K. Onoe. 2002. CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100: 1948-1956.
16. Yanagawa, Y., and K. Onoe. 2003. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of cdc42 and Rac activities. Blood 101: 4923-4929.
17. Sanchez-Sanchez, N., L. Riol-Blanco, G. de la Rosa, J. Garcia-Bordas, D. Martín, N. Longo, A. Cuadrado, C. Cabañas, P. Sanchez-Mateos, and J. L. Rodríguez-Fernández. 2004. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104: 619-625.
18. Marsland, B. J., P. Battig, M. Bauer, C. Ruedl, U. Lassing, R. R. Beerli, K. Dietmeier, L. Ivanova, T. Pfister, L. Vogt, et al. 2005. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22: 493-505.
19. Riol-Blanco, L., N. Sánchez-Sánchez, A. Torres, A. Tejedor, S. Narumiya, A. Corbí, P. Sánchez-Mateos, and J. Rodríguez-Fernández. 2005. The chemokine receptor CCR7 stimulates two signaling pathways that independently modulate chemotaxis and migratory speed of dendritic cells. J. Immunol. 174: 4070-4080.
20. Sanchez-Sanchez, N., L. Riol-Blanco, and J. L. Rodríguez- Fernández. 2006. The multiples personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 176: 5153-5159.
21. Scandella, E., Y. Men, D. F. Legler, S. Gillessen, L. Prikler, B. Ludewig, and M. Groettrup. 2004. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103: 1595-1601.
22. Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18: 6910-6924.
23. Chen, G., and D. V. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
24. Riol-Blanco, L., C. Delgado-Martín, N. Sánchez- Sánchez, L. M. Alonso-C., M. D. Gutiérrez-López, G. Martínez del Hoyo, J. Navarro, F. Sanchez-Madrid, C. Cabañas, P. Sánchez-Mateos, and J. L. Rodríguez-Fernández. 2009. Immunological synapse formation inhibits, via NFκB and FOXO1, the apoptosis of dendritic cells. Nat. Immunol. 10: 753-760.
25. Burgering, B. M. T., and G. J. P. L. Kops. 2002. Cell cycle and death control: long lived Forkheads. Trends Biochem. Sci. 27: 352-360.
26. Birkenkamp, K. U., and P. J. Coffer. 2003. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J. Immunol. 171: 1623-1629.
27. Downward, J. 2004. PI3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15: 177-182.
28. Manning, B. D., and L. C. Cantley. 2007. Akt/PKB signaling: navigating downstream. Cell 129: 1261-1274.
29. Cohen, P., and S. Frame. 2001. The reinascence of GSK3. Nat. Rev. Mol. Cell Biol. 2: 769-776.
30. Doble, B. W., and J. R. Woodgett. 2003. GSK3: tricks of the trade for a multitasking kinase. J. Cell Sci. 116: 391-426.
31. Jope, R. S., and G. V. W. Johnson. 2004. The glamour and gloom of glycogen synthase kinase-3 (GSK3). Trends Biochem. Sci. 29: 95-106.
32. Beurel, E., and R. S. Jope. 2006. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 79: 179-189.
33. Maggirwar, S. B., N. Tong, S. Ramírez, H. A. Gelbard, and S. Dewhurst. 1999. HIV-1 Tat-mediated activation of glycogen synthase kinase-3β contributes to Tat-mediated neurotoxicity. J. Neurochem. 73: 578-586.
34. Hetman, M., J. E. Cavanaugh, D. Kimelman, and Z. Xia. 2000. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20: 2567-2574. (Pubitemid 30220344)
35. Eom, T.-Y., K. A. Roth, and R. S. Jope. 2007. Neural precursor cells are protected from apoptosis induced by trophic factor withdrawal or genotoxic stress by inhibitors of glycogen synthase kinase 3. J. Biol. Chem. 282: 22856-22864.
36. Hoeflich, K. P., J. Luo, E. A. Rubie, M.-S. Tsao, O. Jin, and J. R. Woodgett. 2000. Requirement for glycogen synthase kinase-3β in cell survival and NFκB activation. Nature 406: 86-90.
37. Song, L., T. Zhou, and R. S. Jope. 2004. Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci. 5: 1-7.
38. Ougolkov, A. V., M. E. Fernandez-Zapico, D. N. Savoy, R. A. Urrutia, and D. D. Billedeau. 2005. Glycogen synthase knase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cells. J. Clin. Invest. 65: 2076-2081.
39. Smalley, K. S., R. Contractor, N. K. Haass, A. N. Kulp, G. E. Atilla-Gokcumen, D. S. Williams, H. Bregman, K. T. Flaherty, M. S. Soengas, E. Meggers, and N. Herlyn. 2007. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Res. 67: 209-217.
40. Relloso, M., A. Puig-Kroger, O. Muñiz Pello, J. L. Rodríguez-Fernández, G. de la Rosa, N. Longo, J. Navarro, M. A. Muñoz-Fernández, P. Sánchez-Mateos, and A. L. Corbi. 2002. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-α, and anti-inflammatory agents. J. Immunol. 168: 2634-2643.
41. Rodríguez-Fernández, J. L., M. Gómez, A. Luque, N. Hogg, F. Sánchez-Madrid, and C. Cabañas. 1999. The interaction of activated integrin lymphocyte function-associated antigen 1 with ligand intercellular adhesion molecule 1 induces activation and redistribution of focal adhesion kinase and proline-rich tyrosine kinase 2 in T lymphocytes. Mol. Biol. Cell 10: 1891-1907.
42. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
43. Riol-Blanco, L., T. Iglesias, N. Sánchez-Sánchez, G. De la Rosa, L. Sánchez-Ruiloba, N. Cabrera-Poch, A. Torres, I. Longo, J. García-Bordas, N. Longo, et al. 2004. The neuronal protein Kidins220 localizes in a raft compartment at the leading edge of motile immature dendritic cells. Eur. J. Immunol. 34: 108-118.
44. Schmid, J. A., A. Birbach, R. Hofer-Warbinek, B. Pengg M, U., P. G. Furtmuller, B. R. Binder, and R. de Martin. 2000. Dynamics of NFκB and IκBα studied with green fluorescent protein (GFP) fusion proteins: investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J. Biol. Chem. 275: 17035-17042.
45. Zhang, X., L. Gan, H. Pan, S. Guo, X. He, S. T. Olson, A. Mesecar, S. Adam, and T. G. Unterman. 2002. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms: direct and indirect effects on nuclear/ cytoplasmic shuttling and DNA binding. J. Biol. Chem. 277: 45276-45284.
46. Mempel, T. R., S. E. Henrickson, and U. H. von Andrian. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427: 154-159.
47. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95-105.
48. Bhat, R., Y. Hue, S. Berg, S. Hellberg, M. Ormö, Y. Nilsson, A. C. Radesäter, E. Jerning, P. O. Markgren, T. Borgegård, et al. 2003. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J. Biol. Chem. 278: 45937-45945.
49. Meijer, L., A. L. Skaltsounis, P. Magiatis, P. Polychronopoulos, M. Knockaert, M. Leost, X. P. Ryan, C. A. Vonica, A. Brivanlou, R. Dajani, et al. 2003. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem. Biol. 10: 1255-1266.
50. Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
51. McManus, E. J., K. Sakamoto, L. J. Armit, L. Ronaldson, N. Shpiro, R. Marquez, and D. R. Alessi. 2005. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24: 1571-1583.
52. Pozarowski, P., X. Huang, D. H. Halicka, B. Lee, G. Johnson, and Z. Darzynkiewicz. 2003. Interactions of fluorochrome-labeled caspases inhibitors with apoptotic cells: a caution in data interpretation. Cytometry A 55: 50-60. (Pubitemid 37522521)
53. Lovborg, H., P. Nygren, and R. Larsson. 2004. Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and cyanoguanidine CHS 828. Mol. Cancer Ther. 3: 521-526. (Pubitemid 39193730)
54. s. Proc. Natl. Acad. Sci. USA 94: 14489-14494.
55. Chen, M., L. Huang, Z. Shabier, and J. Wang. 2007. Regulation of the lifespan in dendritic cell subsets. Mol. Immunol. 44: 2558-2565.
56. Chen, M., Y.-H. Wang, Y. Wang, L. Huang, H. Sandoval, Y.-J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
57. Gilley, J., P. J. Coffer, and J. Ham. 2003. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162: 613-622.
58. Kip1 and Bim in response to IL-2. J. Immunol. 168: 5024-5031.
59. Song, J., S. Salek-Ardakani, P. R. Rogers, M. Cheng, L. Van Parijs, and M. Croft. 2004. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat. Immunol. 5: 150-158.
60. Liu, Z., and J. F. Habener. 2009. Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilization of β-catenin and activation of transcription factor 7-like 2 (TCF7L2). Diabetologia 52: 1589-1598.
61. Kriehuber, E., W. Bauer, A.-S. Charbonnier, D. Winter, S. Amatschek, D. Tamandl, N. Schweifer, G. Stingl, and D. Maurer. 2005. The balance between NFκB and JNK/AP-1 activity controls dendritic cell life and death. Blood 106: 175-183.
62. Mattila, J., J. Kallijarvi, and O. Puig. 2008. RNAi screening for kinases and phosphatases identifies FoxO regulators. Proc. Natl. Acad. Sci. USA 105: 14873-14878.
63. Watcharasit, P., G. N. Bijur, L. Songq, J. Xhu, X. Chen, and R. S. Jope. 2003. Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53. J. Biol. Chem. 278: 48872-48879.
64. Maurer, U., C. Charvet, A. S. Waqman, E. Dejardin, and D. R. Green. 2006. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 21: 749-760.
65. Lin, C. F., C.-L. Chen, C.-W. Chiang, M.-S. Jan, W.-C. Huang, and Y.-S. Lin. 2007. GSK-3β acts downstream of PP2A and PI3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis. J. Cell Sci. 120: 2935-2943.
66. Sanchez, J. F., L. F. Sniderhan, A. L. Williamson, S. Fan, S. Chakraborty-Sett, and S. B. Maggirwar. 2003. Glycogen synthase kinase-3-β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling. Mol. Cell. Biol. 23: 4649-4662.
67. Rena, G., Y. L. Woods, E. R. Prescott, M. Peggie, T. G. Unterman, M. R. Williams, and P. Cohen. 2002. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 21: 2263-2271.
68. Jope, R. S., and J. N. Bijur. 2002. Mood stabilizers, glycogen synthase kinase-3β and cell survival. Mol. Psychiatry 7: S35-S45.
69. Prummel, M. F., T. Strieder, and W. M. Wiersinga. 2004. The environment and autoimmune thyroid diseases. Eur. J. Endocrinol. 150: 605-618.
70. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptormediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784.
71. Ono, T., Y. Yanagawa, K. Iwabuchi, K. Nonomura, and K. Onoé. 2007. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization. Immunology 122: 189-198.
72. Rodionova, E., M. Conzelmann, E. Marakovsky, M. Hess, M. Kirsch, T. Giese, A. D. Ho, M. Zoller, and T. Luft. 2007. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 109: 1584-1592.
73. Ohtani, M., S. Nagai, S. Kondo, S. Mizuno, K. Nakamura, M. Tanabe, T. Takeuchi, S. Matsuda, and S. Koyasu. 2008. mTOR and GSK3 differentially regulate LPS-induced IL-12 production in dendritic cells. Blood 112: 635-643.